← All companies

EOLS

Evolus, Inc.

EOLS Nasdaq Pharmaceutical Preparations EDGAR ↗

$6.05

+0.04 +0.67%

Key statistics

from XBRL data in SEC filings

Market cap

$398M

Revenue (TTM)

$302M

Net income (TTM)

-$43.4M

EPS (TTM)

$-0.66

P/E ratio

—

Dividend yield

—

Free cash flow

-$45.7M

Cash

$49.8M

Total assets

$221M

Gross margin

66.1%

52-week range

$3.86 – $9.15

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Regulation FD disclosure Jul 8, 2026 8-K Shareholder vote results Jun 12, 2026 10-Q Quarter ended 2026-03-31 May 4, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 4, 2026 8-K Director or officer change Mar 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 3, 2026 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation Mar 3, 2026 8-K Results of operations (earnings release) Jan 9, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Director or officer change; Regulation FD disclosure Sep 8, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release); Director or officer change Aug 5, 2025 8-K Director or officer change; Shareholder vote results Jun 6, 2025 8-K Director or officer change; Regulation FD disclosure May 27, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure May 5, 2025 10-K Fiscal year ended 2024-12-31 Mar 4, 2025 8-K Results of operations (earnings release) Mar 4, 2025 8-K Results of operations (earnings release) Jan 21, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 10-Q Quarter ended 2024-06-30 Jul 31, 2024 8-K Results of operations (earnings release) Jul 31, 2024 8-K Director or officer change; Regulation FD disclosure Jul 1, 2024 8-K Director or officer change; Shareholder vote results Jun 11, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K Director or officer change Apr 3, 2024 8-K Entered a material agreement Mar 13, 2024 10-K Fiscal year ended 2023-12-31 Mar 7, 2024 8-K Results of operations (earnings release) Mar 7, 2024 8-K Results of operations (earnings release) Jan 16, 2024 8-K Entered a material agreement; Regulation FD disclosure Dec 20, 2023 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Results of operations (earnings release) Nov 7, 2023 10-Q Quarter ended 2023-06-30 Aug 2, 2023 8-K Results of operations (earnings release) Aug 2, 2023 8-K Results of operations (earnings release) Jul 27, 2023